Laboratorios Farmaceuticos Rovi, S.A.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
5/10
|
32.61 | 46.22 | -29.44% | 25.96 | +25.64% |
| P/S |
|
5.84 | 4.38 | 33.38% |
|
|
| P/BV |
|
7.68 | 5.41 | 42% |
|
|
| P/FCF |
|
61.1 | 26.95 | 126.76% |
|
|
| Ev/Ebitda |
|
21.91 | 17.44 | 25.64% |
|
|
| Ev/S |
|
5.96 | 4.5 | 32.4% |
|
|
| Ev/FCF |
|
59.84 | 39.19 | 52.68% |
|
|
| E/P |
|
0.0295 | 1.06 | -97.22% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
8/10
|
27.2 | 23.21 | 17.18% | 29.93 | -9.12% |
| ROE |
|
25.83 | 14.54 | 77.64% |
|
|
| ROA |
|
17.6 | 7.4 | 137.9% |
|
|
| ROIC |
|
0 | 14.06 | -100% |
|
|
| ROS |
|
17.92 | 11.1 | 61.43% |
|
|
| ROCE |
|
30.9 | 17.57 | 75.92% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
9/10
|
0.5507 | 2.91 | -81.08% | 0.392 | +40.49% |
| Nеt Debt/Ebitda |
|
0.4199 | 0.0376 | 1017.58% |
|
|
| Debt/Ratio |
|
0.1375 | 0.2175 | -36.79% |
|
|
| Debt/Equity |
|
0.4307 | 1.12 | -61.47% |
|
|
| Debt/Net Income |
|
0.836 | 9 | -90.71% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
6.83/10
|
2.73 | 1.7 | 60.74% | 1193.82 | -99.77% |
| Number of years of dividend growth |
|
0 | 1.85 | -100% | ||
| DSI |
|
0.8333 | 0.7795 | 6.9% |
|
|
| Average dividend growth |
|
-38.93 | -359.57 | -89.17% |
|
|
| Average percentage for 5 years |
|
1193.82 | 3.31 | 35939.37% |
|
|
| Average percentage for payments |
|
34.08 | 151.74 | -77.54% |
|
|
| Difference from average difference in sector |
|
1.03 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
138.23 | 356.39 | -61.21% | ||
| Growth impulse Ebitda in 5 years |
|
181.24 | 337.43 | -46.29% | ||
| Growth impulse Net Income in 5 years |
|
193.36 | 247.92 | -22.01% | ||
| Growth impulse FCF in 5 years |
|
1281.25 | 229.5 | 458.28% | ||
| Growth impulse EPS in 5 years |
|
217.04 | 436.02 | -50.22% |
IP Score
7.04/10
